Topics

Merck & Co. enters deal with Skyhawk to develop small molecules that modulate RNA splicing https://www.firstwordpharma.com/node/1651806  $MRK

09:40 EDT 8 Jul 2019 | FirstWord Pharma

Merck & Co. enters deal with Skyhawk to develop small molecules that modulate RNA splicing https://www.firstwordpharma.com/node/1651806 

Original Article: Merck & Co. enters deal with Skyhawk to develop small molecules that modulate RNA splicing https://www.firstwordpharma.com/node/1651806  $MRK

NEXT ARTICLE

More From BioPortfolio on "Merck & Co. enters deal with Skyhawk to develop small molecules that modulate RNA splicing https://www.firstwordpharma.com/node/1651806  $MRK"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...